CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 95  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1442
LYS 10.0100
GLU 20.0120
LEU 30.0108
ARG 40.0121
CYS 50.0049
GLN 60.0076
CYS 70.0127
ILE 80.0025
LYS 90.0056
THR 100.0086
TYR 110.0074
SER 120.0219
LYS 130.0484
PRO 140.0240
PHE 150.0119
HIS 160.0161
PRO 170.0160
LYS 180.0321
PHE 190.0098
ILE 200.0069
LYS 210.0139
GLU 220.0104
LEU 230.0171
ARG 240.0162
VAL 250.0125
ILE 260.0156
GLU 270.0167
SER 280.0068
GLY 290.0105
PRO 300.0161
HIS 310.0054
CYS 320.0064
ALA 330.0062
ASN 340.0015
THR 350.0103
GLU 360.0096
ILE 370.0093
ILE 380.0060
VAL 390.0111
LYS 400.0147
LEU 410.0177
SER 420.0350
ASP 430.1442
GLY 440.0329
ARG 450.0193
GLU 460.0139
LEU 470.0041
CYS 480.0037
LEU 490.0021
ASP 500.0115
PRO 510.0090
LYS 520.0101
GLU 530.0156
ASN 540.0152
TRP 550.0050
VAL 560.0065
GLN 570.0089
ARG 580.0084
VAL 590.0085
VAL 600.0055
GLU 610.0094
LYS 620.0093
PHE 630.0015
LEU 640.0031
LYS 650.0146
ARG 660.0082
ALA 670.0392
GLU 680.0223
ASN 690.0098

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.